Aveo Capital Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,896
Closed -$236K 287
2024
Q4
$236K Buy
8,896
+351
+4% +$9.31K 0.03% 318
2024
Q3
$247K Buy
8,545
+525
+7% +$15.2K 0.03% 303
2024
Q2
$224K Sell
8,020
-3,059
-28% -$85.6K 0.03% 295
2024
Q1
$308K Sell
11,079
-35
-0.3% -$973 0.03% 286
2023
Q4
$320K Sell
11,114
-14,828
-57% -$427K 0.04% 261
2023
Q3
$861K Sell
25,942
-700
-3% -$23.2K 0.11% 137
2023
Q2
$977K Buy
26,642
+436
+2% +$16K 0.12% 132
2023
Q1
$1.07M Sell
26,206
-6,024
-19% -$246K 0.14% 112
2022
Q4
$1.65M Buy
32,230
+2,073
+7% +$106K 0.25% 86
2022
Q3
$1.32M Buy
30,157
+6,265
+26% +$274K 0.23% 85
2022
Q2
$1.25M Sell
23,892
-824
-3% -$43.2K 0.21% 97
2022
Q1
$1.28M Sell
24,716
-2,113
-8% -$109K 0.23% 93
2021
Q4
$1.58M Buy
26,829
+16,681
+164% +$985K 0.28% 78
2021
Q3
$436K Sell
10,148
-540
-5% -$23.2K 0.09% 170
2021
Q2
$419K Buy
10,688
+67
+0.6% +$2.63K 0.09% 177
2021
Q1
$385K Buy
+10,621
New +$385K 0.1% 164
2020
Q4
Sell
-8,698
Closed -$303K 141
2020
Q3
$303K Buy
+8,698
New +$303K 0.11% 150
2020
Q2
Sell
-7,531
Closed -$233K 121
2020
Q1
$233K Buy
7,531
+440
+6% +$13.6K 0.11% 134
2019
Q4
$264K Buy
7,091
+698
+11% +$26K 0.1% 159
2019
Q3
$231K Buy
6,393
+90
+1% +$3.25K 0.1% 162
2019
Q2
$256K Sell
6,303
-27
-0.4% -$1.1K 0.11% 153
2019
Q1
$255K Sell
6,330
-129
-2% -$5.2K 0.12% 132
2018
Q4
$267K Sell
6,459
-3
-0% -$124 0.13% 104
2018
Q3
$272K Sell
6,462
-3,781
-37% -$159K 0.12% 104
2018
Q2
$353K Sell
10,243
-129
-1% -$4.45K 0.16% 92
2018
Q1
$349K Buy
10,372
+1,567
+18% +$52.7K 0.15% 94
2017
Q4
$303K Sell
8,805
-603
-6% -$20.8K 0.1% 99
2017
Q3
$319K Buy
9,408
+66
+0.7% +$2.24K 0.11% 86
2017
Q2
$298K Buy
9,342
+1,078
+13% +$34.4K 0.11% 88
2017
Q1
$268K Sell
8,264
-13,541
-62% -$439K 0.1% 92
2016
Q4
$672K Buy
+21,805
New +$672K 0.19% 80